Schedule 13G ownership disclosure

PYXIS ONCOLOGY INC

Common Stock, par value $0.001 per share · CUSIP: 747324101

Event date: 2025-07-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • GordonMD Global Investments LP

    Shares: 3,834,740.00 · Class: 6.2%

  • GordonMD Long Biased Master Fund LP

    Shares: 3,834,740.00 · Class: 6.2%

  • GordonMD Long Biased GP LLC

    Shares: 3,834,740.00 · Class: 6.2%

  • Craig D. Gordon

    Shares: 3,834,740.00 · Class: 6.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-005781
Form type
SCHEDULE 13G
Filer
GordonMD Global Investments LP
CIK
CIK 2039349
Filed
Sep 23, 2025
Reporting period
Jul 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub